Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
Study NCT ID:
NCT06612151
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2024-09-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
Sponsor:
MediLink Therapeutics (Suzhou) Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-23
First Submit QC Date:
None
Study First Post Date:
2024-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-07
Last Update Post Date:
2025-02-11
Last Update Post Date Type:
ACTUAL